Our Science – Gonzalez Website
Frank J. Gonzalez, Ph.D.
Selected Publications |
| 1)
Mejia-Garcia A, Sanchez-Ocampo EM, Galindo-Gomez S, Shibayama M, Reyes-Hernandez O, Guzman-Leon S, Gonzalez FJ, Elizondo G. 2,3,7,8-Tetrachlorodibenzo-p-dioxin enhances CCl4-induced hepatotoxicity in an aryl hydrocarbon receptor-dependent manner. Xenobiotica. 43: 161-8, 2013. [Journal] |
| 2)
Albrecht PP, Torsell NE, Krishnan P, Ehresman DJ, Frame SR, Chang SC, Butenhoff JL, Kennedy GL, Gonzalez FJ, Peters JM. A species difference in the peroxisome proliferator-activated receptor a-dependent response to the developmental effects of perfluorooctanoic acid. Toxicol. Sci. 131: 568-82, 2013. [Journal] |
| 3)
Wejksza K, Lee-Chang C, Bodogai M, Bonzo J, Gonzalez FJ, Lehrmann E, Becker K, Biragyn A. Cancer-Produced Metabolites of 5-Lipoxygenase Induce Tumor-Evoked Regulatory B Cells via Peroxisome Proliferator-Activated Receptor a. J. Immunol. 190: 2575-84, 2013. [Journal] |
| 4)
Cheng J, Krausz KW, Li F, Ma X, Gonzalez FJ. CYP2E1-dependent elevation of serum cholesterol, triglycerides, and hepatic bile acids by isoniazid. Toxicol. Appl. Pharmacol. 266: 245-53, 2013. [Journal] |
| 5)
Johnson CH, Bonzo JA, Cheng J, Krausz KW, Kang DW, Luecke H, Idle JR, Gonzalez FJ. Cytochrome P450 regulation by a-tocopherol in Pxr-null and PXR-humanized mice. Drug Metab. Dispos. 41: 406-13, 2013. [Journal] |
| 6)
Matsubara T, Li F, Gonzalez FJ. FXR signaling in the enterohepatic system. Mol. Cell. Endocrinol. 368: 17-29, 2013. [Journal] |
| 7)
Li F, Lu J, Cheng J, Wang L, Matsubara T, Csanaky IL, Klaassen CD, Gonzalez FJ, Ma X. Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy. Nat. Med. 19: 418-20, 2013. [Journal] |
| 8)
Jiang C, Kim JH, Li F, Qu A, Gavrilova O, Shah YM, Gonzalez FJ. Hypoxia-inducible factor 1a regulates a SOCS3-STAT3-adiponectin signal transduction pathway in adipocytes. J. Biol. Chem. 288: 3844-57, 2013. [Journal] |
| 9)
Kim J, Yamaori S, Tanabe T, Johnson CH, Krausz KW, Kato S, Gonzalez FJ. Implication of intestinal VDR deficiency in inflammatory bowel disease. Biochim. Biophys. Acta. 1830: 2118-28, 2013. [Journal] |
| 10)
Montanez JE, Peters JM, Correll JB, Gonzalez FJ, Patterson AD. Metabolomics: an essential tool to understand the function of peroxisome proliferator-activated receptor alpha. Toxicol Pathol. 41: 410-8, 2013. [Journal] |
| Click Here to View Expanded Bibliography. |
This page was last updated on 4/10/2013.
